P4ML’s Expertise in Genomic Patient Identification, Ties to Middle East Health Initiatives and Irish Biopharmaceutical Roots ...

Our viewpoint is that in cases of ultra rare diseases where there is no commercial model or opportunity for traditional forms of investment, access to gene therapies could be provided via a clinical ...